000 | 01943 a2200541 4500 | ||
---|---|---|---|
005 | 20250518092951.0 | ||
264 | 0 | _c20210201 | |
008 | 202102s 0 0 eng d | ||
022 | _a1664-2392 | ||
024 | 7 |
_a10.3389/fendo.2020.00103 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRomero-Zerbo, Silvana Y | |
245 | 0 | 0 |
_aThe Atypical Cannabinoid Abn-CBD Reduces Inflammation and Protects Liver, Pancreas, and Adipose Tissue in a Mouse Model of Prediabetes and Non-alcoholic Fatty Liver Disease. _h[electronic resource] |
260 |
_bFrontiers in endocrinology _c2020 |
||
300 |
_a103 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAdipose Tissue _xdrug effects |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCytoprotection _xdrug effects |
650 | 0 | 4 | _aDiet, High-Fat |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aInflammation _xetiology |
650 | 0 | 4 |
_aLiver _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 | _aMice, Obese |
650 | 0 | 4 |
_aNon-alcoholic Fatty Liver Disease _xdrug therapy |
650 | 0 | 4 |
_aObesity _xcomplications |
650 | 0 | 4 |
_aPancreas _xdrug effects |
650 | 0 | 4 |
_aPrediabetic State _xdrug therapy |
650 | 0 | 4 |
_aResorcinols _xpharmacology |
700 | 1 | _aGarcía-Fernández, María | |
700 | 1 | _aEspinosa-Jiménez, Vanesa | |
700 | 1 | _aPozo-Morales, Macarena | |
700 | 1 | _aEscamilla-Sánchez, Alejandro | |
700 | 1 | _aSánchez-Salido, Lourdes | |
700 | 1 | _aLara, Estrella | |
700 | 1 | _aCobo-Vuilleumier, Nadia | |
700 | 1 | _aRafacho, Alex | |
700 | 1 | _aOlveira, Gabriel | |
700 | 1 | _aRojo-Martínez, Gemma | |
700 | 1 | _aGauthier, Benoit R | |
700 | 1 | _aGonzález-Mariscal, Isabel | |
700 | 1 | _aBermúdez-Silva, Francisco J | |
773 | 0 |
_tFrontiers in endocrinology _gvol. 11 _gp. 103 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3389/fendo.2020.00103 _zAvailable from publisher's website |
999 |
_c30779047 _d30779047 |